← Back to Vaccine Database

LIPO-5

Peptide based vaccine · VDDBV0458

Target & Classification

HIVHuman immunodeficiency virus
Peptide based vaccine
HIV Infections
Phase 2

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials2

NCT IDPhaseDisease / Condition
NCT00121758 Phase 2HIV Infections
NCT02038842 Phase 2HIV Infections